Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$5.4B |
| 2 |
NVIDIA
NVDA
|
+$388M |
| 3 |
Microsoft
MSFT
|
+$182M |
| 4 |
Amazon
AMZN
|
+$177M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$213M |
| 2 |
Broadcom
AVGO
|
+$103M |
| 3 |
Union Pacific
UNP
|
+$100M |
| 4 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$89.9M |
| 5 |
Marvell Technology
MRVL
|
+$89.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.68% |
| 2 | Industrials | 8.46% |
| 3 | Financials | 6.55% |
| 4 | Consumer Discretionary | 5.99% |
| 5 | Healthcare | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
AstraZeneca
AZN
$257B
| $7.54M | 0.03% |
41,024
-393,300
| -91% | -$69M |
|
427
Dianthus Therapeutics
DNTH
$6.21B
| $7.53M | 0.03% |
182,619
+54,366
| +42% | +$2.11M |
|
428
Logitech
LOGI
$13.8B
| $7.52M | 0.03% |
75,063
+46,069
| +159% | +$5.18M |
|
429
Pan American Silver
PAAS
$22B
| $7.45M | 0.03% |
143,877
-82,825
| -37% | -$3.47M |
|
430
Chubb
CB
$132B
| $7.44M | 0.03% |
23,830
-91,509
| -79% | -$26.8M |
|
431
CNA Financial
CNA
$13.3B
| $7.4M | 0.03% |
155,075
+67,821
| +78% | +$3.13M |
|
|
B
432
Barrick Mining
B
$78.3B
| $7.39M | 0.03% |
169,751
-215,090
| -56% | -$8.07M |
|
433
CALL
BP
BP
$115B
| $7.37M | 0.03% |
+212,200
| New | +$7.44M |
|
434
US Foods
USFD
$23.7B
| $7.36M | 0.03% |
97,693
+66,178
| +210% | +$4.97M |
|
435
GoDaddy
GDDY
$12.3B
| $7.28M | 0.03% |
58,653
+11,904
| +25% | +$1.54M |
|
436
PVH
PVH
$3.62B
| $7.25M | 0.03% |
108,124
+105,532
| +4,071% | +$8.25M |
|
437
DaVita
DVA
$11.1B
| $7.24M | 0.03% |
63,743
+12,080
| +23% | +$1.47M |
|
438
Nike
NKE
$60.5B
| $7.17M | 0.03% |
112,510
+6,380
| +6% | +$416K |
|
439
Lincoln National
LNC
$8.07B
| $7.1M | 0.03% |
159,520
-40,474
| -20% | -$1.69M |
|
440
Bio-Techne
TECH
$11.3B
| $6.99M | 0.03% |
118,799
+20,423
| +21% | +$1.24M |
|
441
Crocs
CROX
$5.85B
| $6.98M | 0.03% |
+81,643
| New | +$6.83M |
|
442
News Corp Class A
NWSA
$16.4B
| $6.98M | 0.03% |
267,289
-72,679
| -21% | -$1.91M |
|
443
Paylocity
PCTY
$8.14B
| $6.98M | 0.03% |
45,739
-118,715
| -72% | -$17.7M |
|
444
iShares 20+ Year Treasury Bond ETF
TLT
$46.3B
| $6.96M | 0.03% |
79,909
+45,790
| +134% | +$4.09M |
|
445
Regal Rexnord
RRX
$11.1B
| $6.92M | 0.03% |
+49,328
| New | +$7.02M |
|
446
Albertsons Companies
ACI
$6.01B
| $6.9M | 0.03% |
402,020
+389,578
| +3,131% | +$6.95M |
|
447
American Electric Power
AEP
$65.8B
| $6.88M | 0.03% |
59,678
+54,804
| +1,124% | +$6.47M |
|
448
Target
TGT
$75.1B
| $6.88M | 0.03% |
70,376
+35,005
| +99% | +$3.23M |
|
449
Albany International
AIN
$1.68B
| $6.87M | 0.03% |
135,480
-80,642
| -37% | -$4.18M |
|
|
SMLR
450
DELISTED
Semler Scientific
SMLR
| $6.86M | 0.03% |
448,410
+405,650
| +949% | +$9.2M |
|
Similar funds
Steve Schonfeld's Q4 2025 Portfolio in Review
As of Q4 2025, Steve Schonfeld held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Steve Schonfeld deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.
- Steve Schonfeld's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
- Steve Schonfeld added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
- Steve Schonfeld's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
- Steve Schonfeld fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
- Steve Schonfeld's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
- Steve Schonfeld opened 620 new positions and closed 789 in Q4 2025.
- Steve Schonfeld's portfolio value rose 28% quarter-over-quarter to $22.6B.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.